QUANTUM X LABS INC. quarterly report, Q1 FY2010

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2010, for Zaxis International Inc. (Note: The input metadata referenced "Quantum X Labs Inc.", but the filing text explicitly identifies the registrant as Zaxis International Inc.). The Company is a Delaware corporation that ceased its former biotechnology operations in 2002 following bankruptcy. It emerged from bankruptcy in 2004 and currently has no present operations. Management's sole plan of operation is to pursue and effect a business combination (acquisition or merger) with a target company, though no specific target or industry has been identified.

Key Financial Metrics

Metric Q1 2010 (Unaudited) Q1 2009 (Unaudited)
Revenue $0 $0
Net Loss $(12,550) $(13,759)
Loss Per Share (Basic & Diluted) $(0.01) $(0.01)
Cash and Cash Equivalents $0 $729
Total Assets $0 $0
Total Liabilities $121,455 $108,905
Stockholders' Deficiency $(121,455) $(108,905)

Liquidity and Debt: The Company has no cash on hand. Total liabilities consist primarily of advances from and accruals due to related parties ($80,855) and a convertible note ($35,000). The filing states the Company has no agreements to issue debt or equity securities and cannot predict if financing will be available.

Material Changes vs. Prior Period

  • Operating Expenses: General and administrative expenses decreased from $13,757 in Q1 2009 to $11,500 in Q1 2010. However, interest expense of $1,050 was recorded in Q1 2010, compared to $0 in the prior year.
  • Liabilities: Total liabilities increased by approximately $12,550, driven by an increase in advances from related parties and accrued expenses.
  • Cash Flow: The Company reported $0 cash flow from operating activities for the quarter, compared to a net cash outflow of $88 in the prior year. This was due to expenses being paid by related parties or through non-cash adjustments rather than cash outlays.

Outlook, Risks, and Management Commentary

Plan of Operation: Management intends to use limited resources to identify a target business for acquisition. They believe current market uncertainty creates opportunities for acquisitions, but they have not identified a specific target or industry.

Risks and Contingencies:

  • Lack of Diversification: The Company will likely effect only a single business combination, making its success entirely dependent on that single entity.
  • Financing Risk: The Company has no cash and relies on potential future financing (debt or equity) to complete a transaction. There is no assurance such funds will be available.
  • Target Evaluation: Investors cannot evaluate the merits of a target business as none has been selected. The target may be financially unstable or in early development stages.
  • Dilution: A business combination may involve issuing a substantial number of restricted shares, resulting in significant dilution to existing shareholders.

Controls: Management concluded that disclosure controls and procedures were effective as of March 31, 2010.

Investor Verification Checklist

  • Verify the Company's current cash balance is $0 and confirm the status of the $121,455 in liabilities owed to related parties.
  • Confirm whether any specific target acquisition has been identified since the filing date, as none was disclosed in this report.
  • Review the terms of the $35,000 convertible note to understand potential dilution or repayment obligations.
  • Assess the ability of the sole officer/director (Ivo Heiden) to secure financing or identify a viable target given the Company's shell status.
  • Check for any subsequent filings regarding unregistered sales of equity or changes in the plan of operation.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.